Download
1 / 1
10 likes | 90 Views
Pharmacovigilance companies handle triage documents manually which is not only very slow process & but also prone to human error & not readily auditable. Read more about biotech firms transforming their triage process to ensure compliance and reduce risk.
E N D
Drug Safety & Risk Management - Transforming Triage Process in Biotech Firm If you’re like most pharmacovigilance departments, you’re inundated with adverse event reports from multiple sources using a variety of differing communication mediums and formats. These events have to be reported to regulatory authorities to maintain and track all the information related to adverse events, including follow-ups and potential duplicates with full traceability to support regulatory inspection. Typically, companies have handled these triaged documents manually – in spreadsheets or even paper binders. This process is not only painfully slow and resource-intensive but also prone to human error and is not readily auditable. Read the success story to learn how a leading biotech firm deployed ArisGlobal’s industry-leading drug safety system as a complement to their adverse event processing in Oracle Argus. ArisGlobal solutions enabled the transformation of a manually-based triage process into an automated, best-in-class workflow that more effectively captured adverse events and adverse drug interactions which helped ensure compliance and reduced risk. Contact us to learn how ArisGlobal can help your team transform their PV and safety processes too.
